Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice
- 15 February 1988
- journal article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 85 (1), 101-104
- https://doi.org/10.1016/0304-3940(88)90436-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessaryNeuroscience Letters, 1987
- Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in Parkinsonian and normal human brainsBiochemical and Biophysical Research Communications, 1987
- 4-Phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosetsNeuroscience Letters, 1987
- Inhibition of the Tyrosine Hydroxylase System by MPTP, 1-Methyl-4-phenylpyridinium Ion (MPP+) and the Structurally Related Compounds in vitro and in vivoEuropean Neurology, 1987
- Mitochondria and the neurotoxicity of MPTPTrends in Pharmacological Sciences, 1986
- The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slicesBrain Research, 1986
- The Clinical Syndrome of Striatal Dopamine Deficiency: Parkinsonism Induced by MPTPNew England Journal of Medicine, 1985
- Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouseNeuroscience Letters, 1985
- MPTP and parkinson's diseaseTrends in Neurosciences, 1985
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983